These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 24533532

  • 21. Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065).
    Yamaguchi S, Nishimura R, Yaegashi N, Kiguchi K, Sugiyama T, Kita T, Kubushiro K, Kokawa K, Hiura M, Mizutani K, Yamamoto K, Takizawa K.
    Oncol Rep; 2012 Aug; 28(2):487-93. PubMed ID: 22614251
    [Abstract] [Full Text] [Related]

  • 22. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
    Li XF, Li YH, Gao YN, Li CL, Yue HZ, Xu G, Li DM, Su X.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134
    [Abstract] [Full Text] [Related]

  • 23. Multi-institutional Observational Study of Prophylactic Extended-Field Concurrent Chemoradiation Therapy Using Weekly Cisplatin for Patients With Pelvic Node-Positive Cervical Cancer in East and Southeast Asia.
    Wakatsuki M, Kato S, Ohno T, Banu PA, Hoang NC, Yadamsuren E, Supriana N, Cao J, Devi CRB, Calaguas MJ, Chansilpa Y, Cho CK, Adylkhanov T, Okonogi N, Nakano T, Tsujii H.
    Int J Radiat Oncol Biol Phys; 2019 Sep 01; 105(1):183-189. PubMed ID: 31125594
    [Abstract] [Full Text] [Related]

  • 24. Prospective study of daily low-dose nedaplatin and continuous 5-fluorouracil infusion combined with radiation for the treatment of esophageal squamous cell carcinoma.
    Osawa S, Furuta T, Sugimoto K, Kosugi T, Terai T, Yamade M, Takayanagi Y, Nishino M, Hamaya Y, Kodaira C, Yamada T, Iwaizumi M, Takagaki K, Yoshida K, Kanaoka S, Ikuma M.
    BMC Cancer; 2009 Nov 22; 9():408. PubMed ID: 19930599
    [Abstract] [Full Text] [Related]

  • 25. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC, Wang L, Lin JC, Jan JS.
    J Formos Med Assoc; 2015 Mar 22; 114(3):231-7. PubMed ID: 25777974
    [Abstract] [Full Text] [Related]

  • 26. A phase II study of bevacizumab in combination with definitive radiotherapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma: preliminary results of RTOG 0417.
    Schefter TE, Winter K, Kwon JS, Stuhr K, Balaraj K, Yaremko BP, Small W, Gaffney DK.
    Int J Radiat Oncol Biol Phys; 2012 Jul 15; 83(4):1179-84. PubMed ID: 22342094
    [Abstract] [Full Text] [Related]

  • 27. Multi-institutional phase II clinical study of concurrent chemoradiotherapy for locally advanced cervical cancer in East and Southeast Asia.
    Kato S, Ohno T, Thephamongkhol K, Chansilpa Y, Yuxing Y, Devi CR, Bustam AZ, Calaguas MJ, de los Reyes RH, Cho CK, Dung TA, Supriana N, Mizuno H, Nakano T, Tsujii H.
    Int J Radiat Oncol Biol Phys; 2010 Jul 01; 77(3):751-7. PubMed ID: 19836154
    [Abstract] [Full Text] [Related]

  • 28. Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer.
    Abou-Taleb HA, Koshiyama M, Matsumura N, Baba T, Yamaguchi K, Hamanishi J, Abiko K, Yamanoi K, Murakami R, Horikawa N, Taha AA, Kitamura S, Konishi I.
    J Int Med Res; 2016 Apr 01; 44(2):346-56. PubMed ID: 26831404
    [Abstract] [Full Text] [Related]

  • 29. A phase I study of concurrent weekly topotecan and cisplatin chemotherapy with whole pelvic radiation therapy in locally advanced cervical cancer: a gynecologic oncology group study.
    Rose PG, Sill MW, McMeekin DS, Ahmed A, Salani R, Yamada SD, Wolfson AH, Fusco N, Fracasso PM.
    Gynecol Oncol; 2012 Apr 01; 125(1):158-62. PubMed ID: 22198338
    [Abstract] [Full Text] [Related]

  • 30. Low-dose, prophylactic, extended-field, intensity-modulated radiotherapy plus concurrent weekly cisplatin for patients with stage IB2-IIIB cervical cancer, positive pelvic lymph nodes, and negative para-aortic lymph nodes.
    Liang JA, Chen SW, Hung YC, Yeh LS, Chang WC, Lin WC, Chang YY.
    Int J Gynecol Cancer; 2014 Jun 01; 24(5):901-7. PubMed ID: 23975081
    [Abstract] [Full Text] [Related]

  • 31. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.
    Marnitz S, Martus P, Köhler C, Stromberger C, Asse E, Mallmann P, Schmidberger H, Affonso Júnior RJ, Nunes JS, Sehouli J, Budach V.
    Int J Radiat Oncol Biol Phys; 2016 Feb 01; 94(2):243-53. PubMed ID: 26853333
    [Abstract] [Full Text] [Related]

  • 32. Highly conformal combined radiotherapy with cisplatin and gemcitabine for treatment of loco-regionally advanced cervical cancer - a retrospective study.
    Cihoric N, Tsikkinis A, Vlaskou Badra E, Glatzer M, Novak U, Scherz A, Shelan M, Soldatovic I, Yojena CKK, Aebersold DM, Lössl K.
    Radiat Oncol; 2017 Dec 22; 12(1):202. PubMed ID: 29273076
    [Abstract] [Full Text] [Related]

  • 33. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD, Rai B, Mallick I, Sharma SC.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):125-30. PubMed ID: 15850912
    [Abstract] [Full Text] [Related]

  • 34. [Locally advanced carcinoma of the cervix uteri (stage IIB-IIIB TNM-UICC): radiotherapy combined with simultaneous daily low-dose platinum. Phase II study].
    Micheletti E, La Face B, Bianchi E, Cagna E, Sartori E.
    Radiol Med; 1996 May 01; 91(5):628-34. PubMed ID: 8693131
    [Abstract] [Full Text] [Related]

  • 35. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
    Kim JS, Kim JS, Kim SY, Kim Ki, Cho MJ.
    Int J Radiat Oncol Biol Phys; 2003 Apr 01; 55(5):1247-53. PubMed ID: 12654434
    [Abstract] [Full Text] [Related]

  • 36. Phase I trial of nedaplatin chemotherapy concurrent with radiotherapy for untreated locoregionally advanced nasopharyngeal carcinoma.
    Liang Z, Wang S, Lin Z, Feng S, Cheng Z, Yang Y, Kuang Y, Fidelis C, Ullah S, Li F.
    Cancer Chemother Pharmacol; 2016 Mar 01; 77(3):643-51. PubMed ID: 26831498
    [Abstract] [Full Text] [Related]

  • 37. Neoadjuvant chemotherapy with docetaxel and carboplatin followed by radical hysterectomy for stage IB2, IIA2, and IIB patients with non-squamous cell carcinoma of the uterine cervix.
    Shimada M, Nagao S, Fujiwara K, Takeshima N, Takizawa K, Shoji T, Sugiyama T, Yamaguchi S, Nishimura R, Kigawa J.
    Int J Clin Oncol; 2016 Dec 01; 21(6):1128-1135. PubMed ID: 27380169
    [Abstract] [Full Text] [Related]

  • 38. Concurrent chemotherapy with high-dose rate brachytherapy after treatment with chemoradiotherapy in cases of locally advanced carcinoma cervix: A study from rural area of Maharashtra, India.
    Jain VS, Virkar M, Sarje MB, Waghmare CM, Patel S, Jain SM.
    J Cancer Res Ther; 2022 Dec 01; 18(6):1572-1577. PubMed ID: 36412413
    [Abstract] [Full Text] [Related]

  • 39. Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: A mono-institutional experience.
    Lakosi F, de Cuypere M, Viet Nguyen P, Jansen N, Warlimont B, Gulyban A, Gennigens C, Seidel L, Delbecque K, Coucke P, Hermesse J, Kridelka F.
    Acta Oncol; 2015 Dec 01; 54(9):1558-66. PubMed ID: 26406152
    [Abstract] [Full Text] [Related]

  • 40. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
    Wang W, Hou X, Yan J, Shen J, Lian X, Sun S, Liu Z, Meng Q, Wang D, Zhao M, Qiu J, Hu K, Zhang F.
    BMC Cancer; 2017 Aug 01; 17(1):510. PubMed ID: 28764676
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.